Athenex, Inc. (ATNX): Price and Financial Metrics


Athenex, Inc. (ATNX)

Today's Latest Price: $14.78 USD

0.12 (-0.81%)

Updated Feb 14 12:00am

Add ATNX to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 215 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

ATNX Stock Summary

  • ATNX's went public 2.67 years ago, making it older than merely 7.84% of listed US stocks we're tracking.
  • Of note is the ratio of Athenex Inc's sales and general administrative expense to its total operating expenses; merely 22.13% of US stocks have a lower such ratio.
  • ATNX's price/sales ratio is 13.56; that's higher than the P/S ratio of 91.44% of US stocks.
  • Stocks that are quantitatively similar to ATNX, based on their financial statements, market capitalization, and price volatility, are SQNS, KPTI, XPL, CLSN, and CLVS.
  • Visit ATNX's SEC page to see the company's official filings. To visit the company's web site, go to www.athenex.com.
ATNX Daily Price Range
ATNX 52-Week Price Range

ATNX Stock Price Chart More Charts


ATNX Price/Volume Stats

Current price $14.78 52-week high $21.11
Prev. close $14.90 52-week low $8.82
Day low $14.59 Volume 270,800
Day high $14.93 Avg. volume 450,906
50-day MA $15.10 Dividend yield N/A
200-day MA $14.90 Market Cap 1.21B

Athenex, Inc. (ATNX) Company Bio


Athenex Inc. is a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer. The company was founded in 2003 and is based in Buffalo, New York.


ATNX Latest News Stream


Event/TimeNews Detail
Loading, please wait...

ATNX Latest Social Stream


Loading social stream, please wait...

View Full ATNX Social Stream

ATNX Price Returns

1-mo -3.21%
3-mo -4.77%
6-mo -6.16%
1-year 16.93%
3-year N/A
5-year N/A
YTD -3.21%
2019 20.33%
2018 -20.19%
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.5864 seconds.